Navigation Links
Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab

Clinical Phase I and II data presented at American Society of Clinical Oncology (ASCO) 2007 Annual Meeting

CHICAGO, June 05, 2007 /PRNewswire-FirstCall/ -- Medarex, Inc. and Bristol-Myers Squibb Company today presented results from multiple clinical studies of ipilimumab (MDX-010), an investigational immunotherapy, for patients with advanced melanoma. The results demonstrated an anti-tumor response in some patients with advanced melanoma either as a monotherapy or in combination with other therapies. The results of the monotherapy study showed that 19% of patients (17/88) with advanced melanoma treated with ipilimumab experienced control of their disease, including tumor shrinkage and stabilization. The second presentation showed that complete or partial response was achieved in 13% of patients (46/356) with advanced melanoma when treated with ipilimumab alone or in combination with traditional chemotherapy (i.e., dacarbazine), interleukin-2, or a gp100 peptide vaccine. The results of this analysis also indicated that treatment with ipilimumab may take 12 weeks or longer to induce a response. These findings were presented at the American Society of Clinical Oncology's 2007 Annual Meeting in Chicago.

"In recent years, there have been limited advancements in the treatment of melanoma, particularly in the later stages of the disease," said Rachel Humphrey, MD, Vice President of Development at Bristol-Myers Squibb. "These studies represent an important advance in our understanding of how ipilimumab may work as a potential anti-cancer therapy for patients with this devastating disease."

(Abstract #8523) Results from a Phase II dose-escalation trial presented by Jeffrey S. Weber, MD, PhD, who was Chief of Oncology at the Keck School of Medicine at the University of Southern California at the time of the study, suggested that the anti-tumor response evolves over time in certain patients treated with ipil
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
2. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
3. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia
6. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
7. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
8. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine
9. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)
Post Your Comments:
(Date:9/29/2014)... , Sept. 29, 2014 Adaptive ... Next Generation Sequencing to profile the adaptive immune ... Scientific Advisory Board to provide strategic and clinical ... suite of assays in the diagnosis and monitoring ... focus of the SAB will be to support ...
(Date:9/29/2014)... BOSTON , Sept. 29, 2014  Arisaph ... on discovery and development of novel therapies for ... has been awarded a phase II Small Business ... I grant, both from the National Cancer Institute ... II award of $1,066,916 supports research and development ...
(Date:9/29/2014)... TEL-AVIV, Israel , Sept. 29, 2014 /PRNewswire/ ... ) ("Galmed"), a clinical-stage biopharmaceutical company focused on ... medication for the treatment of liver diseases and ... EndoPAT™ devices and accessories from Itamar Medical Ltd. ... company whose technology has been cleared by the ...
Breaking Medicine Technology:Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 2Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 3Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 2Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 3Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 4Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 2Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 3
... Hospira, Inc. (NYSE: HSP ... announced positive results from a Phase I U.S. clinical ... renal (kidney) dysfunction who have anemia. Hospira,s trial met ... and distribution in the body, for Hospira,s EPO and ...
... 6, 2011 Omthera Pharmaceuticals, Inc., a privately-held emerging ... and Chief Executive Officer, will present at the Rodman ... 2011 at 2:25pm ET at the Waldorf Astoria Hotel ... Pharmaceuticals, Inc. Founded in 2008, Omthera ...
Cached Medicine Technology:Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 2Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 3
(Date:9/29/2014)... Garden City, NY (PRWEB) September 30, 2014 ... , R.N., B.S.N., Clinical Manager Specialist, as a 2014 ... with this prestigious distinction for leadership in clinical care. ... the country, spanning virtually every industry and profession, the ... networking community with over 600,000 members and nearly 300 ...
(Date:9/29/2014)... Park Avenue Dental, a leading ... A. Sherman who has dedicated his career to providing ... announced its inclusion in the Patient Connect 365 dentist ... to private accounts so that they may manage online ... system also allows patients to request appointments, better communicate ...
(Date:9/29/2014)... According to the senior spokesman for Fecbek, the ... and was worn by a man, Ötzi the Iceman. ... the direction of using small ornamental purses—which evolved into ... a leading online supplier of fashion accessories, has released ... are fashionable. , For most men, they do ...
(Date:9/29/2014)... Chicago, IL (PRWEB) September 29, 2014 ... the option to review life insurance quotes from top ... search tool available now presents price exploration options at ... quotations are now presented inside of the formatted consumer ... insurers. The life plans that are offered to review ...
(Date:9/29/2014)... Humility of Mary Health Partners will offer SlimDown, ... and Velma Davis Family YMCA in Boardman and St. Joe’s ... manage their weight by making lifestyle changes with regard to ... to 6:30 p.m. Wednesdays at the YMCA, 2045 McClurg Road, ... the Mall (next to the rear entrance to Sears) beginning ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Sarah Shiermeister, Clinical Manager Specialist at Gentiva Health Services, a 2014 Professional Woman of the Year 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 3Health News:Life Insurance Quotes for Chicago Residents Now Quoted Using New Agency Tool Online 2Health News:Humility of Mary Health Partners Offers SlimDown Classes 2
... those at risk, expert says, , FRIDAY, Aug. 14 (HealthDay ... bones in older men, says a new study. , The ... 65 and older who had their sex hormone levels measured ... with low levels of estradiol or high levels of sex ...
... , , TUSTIN, Calif., Aug. ... company with major operations in China, announced today it has filed ... Exchange Act of 1934, as amended, with the Securities and Exchange ... the second quarter ended June 30, 2009. This filing provides for ...
... , WESTON, Fla., Aug. 14 Kidz-Med, ... Sheets: ASFX), is announcing a change in the distribution channels of ... Recently, the Company has learned of Walgreens, intent to cut many ... including the Kidz-Med Thermofocus. To the Company,s knowledge, this decision is ...
... , , Additional 28 ... WASHINGTON, Aug. 14 Today, Secretary of Veterans Affairs Eric ... other assistance in 28 additional communities across the country where the ... , , "VA is committed to providing ...
... , , EDINA, Minn., Aug. 14 ... Assure blood glucose meter test strips do not use GDH-PQQ (glucose ... blood glucose results in patients who are using certain therapeutic products. ... of products use a glucose-specific enzyme and can, therefore, distinguish between ...
... , , WHITE PLAINS, N.Y., ... Next Generation Nutrition Grants, donating a total of $120,000 to four non-profit ... families. , , (Photo: http://www.newsc ... 7 67 ) , , Through ...
Cached Medicine News:Health News:Sex Hormone Levels Linked to Fractures in Men 2Health News:AMDL Inc. Files Notification of Late Filing for Form 10-Q 2Health News:Child Health and Safety Product Distribution Channel Changes 2Health News:Secretary Shinseki Announces Expansion of Counseling for Combat Veterans 2Health News:ARKRAY Statement Regarding U.S. Food and Drug Administration's Public Health Notification: Potentially Fatal Errors With GDH-PQQ Glucose Monitoring Technology 2Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 2Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 3Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 4Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 5Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 6Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 7
... FH system uses a ... infrastructure operating in ... communication of patient information. ... of up to 640 ...
Spacelabs offers an approach that allows your telemetry and step-down units to configure systems to meet their telemetry requirements. Our modular telemetry system data are integrated into the depart...
ISI Alumi-Hand is the safe, sterile, ready-to-use ,surgical hand immobilizer....
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
Medicine Products: